Determination of the presence of specific antibodies against SARS-CoV-2 school-age children in Kharkiv in September 2020
Ключові слова:
Covid-19 school-age children, antibodies to SARS-CoV-2Анотація
Introduction. Recently, the world community and modern medical science have faced the challenge of the emergence new human coronavirus SARS-CoV-2 capable of causing severe acute respiratory syndrome. WHO has named the disease caused by this virus Covid-19 (coronavirus infection disease). SARS-CoV-2 was first detected in December 2019 in Wuhan, from where it quickly spread to China and further around the world. Due to the high contagiousness and pathogenicity of SARS-CoV-2, WHO declared the global pandemic Covid-19 in early March 2020. The features of the pathogenesis of Covid-19 determine the significant frequency cases of this disease with a severe course. The severity course of the disease and the consistency and completeness of the immune response are interrelated: excessive and continued activation of innate immunity factors with an increase in the cytokine profile is observed in patients with severe course, and the transition to the stage of production the specific antibodies is characterized by an improvement in the patient's condition and recovery. The specific humoral response is important in the formation of collective post-infection and post-vaccination immunity and is an indicator of overcoming epidemic processes in the population. The study is conducted in the Mechnikov institute of microbiology and immunology National Academy of Medical Sciences of Ukraine has one of the tasks of determining specific antibodies to SARS-CoV-2 in different age groups and monitoring the formation of the immune layer during the epidemic process, as well as the duration of detection of specific antibodies. Material & methods. A study was conducted to determine specific total immunoglobulins, IgA, IgM and IgG to SARS-CoV-2 by enzyme-linked immunosorbent assay (ELISA) among schoolchildren Kharkiv gymnasium №X for 27-28 weeks of the pandemic (21-24/09/2020). The object of the study were 439 samples of serum from children aged 6 to 16 years. Results & discussion. This phase of the study the presence of specific SARS-CoV-2 antibodies in certain groups held at a time when the territory of Ukraine still it was not observed a significant increase in the number of patients with Covid-19 compared to Western Europe, China, the USA and others, but with almost 6 months have passed since the beginning of the pandemic. Most of the patients (98.4 %) in a survey questionnaire and not noted the manifestations of acute respiratory illness, excessive fatigue, temperature rise or other manifestations characteristic of Covid-19. The study revealed total SARS-CoV-2 antibodies in 20.3% of children, questionable levels total antibodies were found in almost 9 %. IgA was detected (positive and questionable) in 15.2 % of children, IgM – 7.7 %, and IgG – 14.3 %. In serum samples total SARS-CoV-2 antibody positive/questionable in 23.6% of cases were identified only one of the classes of immunoglobulins: IgA at 5,6 %, IgM – 3,3 %, IgG – 14,7 %. In most samples two classes of antibodies were detected simultaneously – 67.4 % of samples and in 9.02% all three classes of immunoglobulins were detected simultaneously. An interesting fact is predominantly simultaneous presence in serum IgA and IgG in 60 samples (46.9%) with total serum antibodies to SARS-CoV-2. Simultaneous detection IgM and IgG was noted much less, only in 29 samples – 22.7%, the combination of simultaneous presence IgA and IgM without presence IgG was detected in one sample (0.78%). Conclusion. The data obtained indicate that more than 20% of school-age children in the randomized sample had antibodies to SARS-CoV-2 at 27-28 weeks of the pandemic (21-24/09/2020), despite the fact that at the time of this study, our country has not yet faced an avalanche of rising morbidity, which was observed in this period. Covid-19 is known to be milder, asymptomatic or asymptomatic in children, which is consistent with our lack of evidence in most children for 6-8 weeks prior to the study, although it is possible to assume that the infection occurred earlier. However, the simultaneous presence in the serum SARS-CoV-2 IgA and IgG in 60 samples (46.9%) and IgM and IgG in 29 samples – in 22.7%, which is approximately three quarters of all children, which had positive antibodies to SARS-CoV-2, according to traditional notions about the frequency of the formation humoral response suggests a higher probability of infection during this period to the coin determination of antibodies in blood serum. Obtained in this study data provide an understanding certain features of the formation SARS-CoV-2 post infectious immunity in school-age children and delivered important issues that require further research. Keywords: Covid-19 school-age children, antibodies to SARS-CoV-2
DOI: 10.5281/zenodo.4382196
Посилання
Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) // Ind J Pediatr. 2020. Vol. 87. N. 4. P. 281–6. Google Scholar
Wu F, Zhao S, Yu B. [et al.] A new Coronavirus associated with human respiratory disease in China // Nature. 2020. Vol. 579. P. 265–269. CAS PubMed PubMed Central Google Scholar
Weekly epidemiological update - 27 October 2020/Data as received by WHO from national authorities, as of 10am CEST 25/October/2020. URL:https://www.who.int/publications/m/item/weekly-epidemiological-update---27-october-2020
Huang C, Wang Y, Li X. [et al.] Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // The Lancet. 2020. Vol. 395. P. 497–506. PMC free article PubMed Google Scholar
Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis // J. Med. Virol. 2020. Vol. 92. P. 418–423. PMC free article PubMed Google Scholar
Ahmad Abu Turab Naqvi, Kisa Fatima, Taj Mohammad. [et al.] Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach // Biochim Biophys Acta Mol Basis Dis. 2020. Oct 1. Vol. 1866. N. 10. P. 165878. Published online 2020 Jun 13. URL:doi: 10.1016/j.bbadis.2020.165878 PMCID: PMC7293463 PMID: 32544429
L.V. Kuznetsova, V.D. Babajan, N.V. Kharchenko [et al.] Immunology// Vinnytsia Mercury-Podillya LLC. 2013.
URL: https://nmapo.edu.ua/images/FakTer/KafKlimAle/Imunologiy.pdf
Stawicki S.P., Jeanmonod R., Miller А.С. [et al.] The 2019–2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper // J Glob Infect Dis. 2020 Apr-Jun; 12(2): 47–93.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384689/
Ortiz-Prado Е., Simbaña-Rivera К., Gómez-Barreno L. [et al.] Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review // Diagn Microbiol Infect Dis. 2020 Sep; 98(1): 115094.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260568/
Kyrychko Y.N., Blyuss K.B., Brovchenko I. Mathematical modelling of the dynamics and containment of COVID-19 in Ukraine // Sci Rep. 2020; 10: 19662.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665000/
Ioannidis J.P. Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic // Eur J Clin Invest. 2020. Oct 25: e13423.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646031/
Saha J., Barman B., Chouhan P. Lockdown for COVID-19 and its impact on community mobility in India: An analysis of the COVID-19 Community Mobility Reports, 2020 // Child Youth Serv Rev. 2020 Sep; 116: 105160.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289746/
Hoang A., Chorath K., Moreira A. [et al.] COVID-19 in 7780 pediatric patients: A systematic review // EClinicalMedicine. 2020 Jul; 24: 100433.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318942/
Bouteau A., Kervevan J., Su Q. [et al.] DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells // Front Immunol. 2019; 10: 1134.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545976/
Vabret N., Britton G.J., Gruber C. [et al.] Immunology of COVID-19: Current State of the Science // Immunity. 2020 Jun 16; 52(6): 910–941.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200337/
Altman D. Abstracts of the Annual Congress of the British Society for Immunology 5–8 December 2011 Liverpool, UK // Immunology The Journal of cells, molecules, systems and technologies. Volume 135, Suppl. 1, December 2011
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246641/pdf/imm0135-0001.pdf
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2020 Annals of Mechnikov's Institute
Ця робота ліцензованаІз Зазначенням Авторства – Некомерційна – Без Похідних 3.0 Міжнародна.